缬沙坦联合氨氯地平治疗原发性高血压的临床疗效观察

Clinical Efficacy of Valsartan Combined with Amlodipine in the Treatment of Essential Hypertension

目的对缬沙坦联合氨氯地平治疗原发性高血压的临床疗效进行观察分析。方法选取我院2017年1月至2018年12月收治的320例原发性高血压患者作为研究对象,将其按照治疗方法的不同分为对照组(160例,使用缬沙坦进行治疗)和治疗组(160例,使用缬沙坦联合氨氯地平进行治疗),对两组患者的治疗效果进行整理和分析。结果两组患者在进行治疗后病情均有一定程度上的好转,但治疗组的总有效率显著高于对照组,差异具有统计学意义(P<0.05)。结论在对原发性高血压患者进行治疗时,使用缬沙坦联合氨氯地平的治疗方法能够取得更加显著的临床疗效,有较高的使用价值。

Objective To observe the clinical efficacy of Valsartan combined with Amlodipine in the treatment of essential hypertension.Methods A total of 320 patients with essential hypertension admitted to our hospital from January 2017 to December 2018 were enrolled in the study.According to the different treatment methods,they were divided into control group(160 cases,treated with valsartan)and treatment group(160 cases,treated with valsartan and amlodipine),and analyze the therapeutic effects of the two groups.Results The patients in both groups had a certain degree of improvement after treatment,but the total effective rate of the treatment group was significantly higher than that of the control group,and the difference was statistically significant(P<0.05).Conclusion In the treatment of patients with essential hypertension,the treatment with valsartan combined with amlodipine can achieve more significant clinical efficacy and has a higher value.